Your browser doesn't support javascript.
loading
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.
Pache, Florence; Zimmermann, Hanna; Mikolajczak, Janine; Schumacher, Sophie; Lacheta, Anna; Oertel, Frederike C; Bellmann-Strobl, Judith; Jarius, Sven; Wildemann, Brigitte; Reindl, Markus; Waldman, Amy; Soelberg, Kerstin; Asgari, Nasrin; Ringelstein, Marius; Aktas, Orhan; Gross, Nikolai; Buttmann, Mathias; Ach, Thomas; Ruprecht, Klemens; Paul, Friedemann; Brandt, Alexander U.
Afiliação
  • Pache F; NeuroCure Clinical Research Center (NCRC), Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
  • Zimmermann H; Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Mikolajczak J; NeuroCure Clinical Research Center (NCRC), Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
  • Schumacher S; Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Lacheta A; NeuroCure Clinical Research Center (NCRC), Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
  • Oertel FC; NeuroCure Clinical Research Center (NCRC), Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
  • Bellmann-Strobl J; NeuroCure Clinical Research Center (NCRC), Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
  • Jarius S; NeuroCure Clinical Research Center (NCRC), Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
  • Wildemann B; NeuroCure Clinical Research Center (NCRC), Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
  • Reindl M; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Waldman A; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
  • Soelberg K; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
  • Asgari N; Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Ringelstein M; Division of Neurology, Children's Hospital of Philadelphia, Pennsylvania, USA.
  • Aktas O; Department of Neurology, Vejle Hospital, Vejle, Denmark.
  • Gross N; Department of Neurobiology, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
  • Buttmann M; Department of Neurology, Vejle Hospital, Vejle, Denmark.
  • Ach T; Department of Neurobiology, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
  • Ruprecht K; Department of Neurology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Paul F; Department of Neurology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Brandt AU; Department of Ophthalmology, Medical Faculty, University of Freiburg, Freiburg, Germany.
J Neuroinflammation ; 13(1): 282, 2016 11 01.
Article em En | MEDLINE | ID: mdl-27802824

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Retinianas / Imunoglobulina G / Neurite Óptica / Aquaporina 4 / Glicoproteína Mielina-Oligodendrócito Tipo de estudo: Clinical_trials / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Retinianas / Imunoglobulina G / Neurite Óptica / Aquaporina 4 / Glicoproteína Mielina-Oligodendrócito Tipo de estudo: Clinical_trials / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article